<SEC-DOCUMENT>0001062993-15-003421.txt : 20150617
<SEC-HEADER>0001062993-15-003421.hdr.sgml : 20150617
<ACCEPTANCE-DATETIME>20150617165047
ACCESSION NUMBER:		0001062993-15-003421
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150615
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20150617
DATE AS OF CHANGE:		20150617

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANAVEX LIFE SCIENCES CORP.
		CENTRAL INDEX KEY:			0001314052
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				208365999
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51652
		FILM NUMBER:		15937625

	BUSINESS ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163
		BUSINESS PHONE:		800-689-3939

	MAIL ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thrifty Printing Inc.
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>



<HTML>
<HEAD>
   <TITLE>Anavex Life Sciences Corp.: Form 8-K - Filed by newsfilecorp.com</TITLE>

</HEAD>

<BODY style="font-size:10pt;">

<HR noshade align="center" width=100% size=3 color="black">
<A name=page_1></A>
<P align=center><B><FONT size=5>UNITED STATES </FONT></B><BR><B><FONT
size=5>SECURITIES AND EXCHANGE COMMISSION </FONT></B><BR>Washington, D.C.
20549<B> </B></P>
<P align=center><B><FONT size=5>FORM 8-K </FONT></B></P>
<P align=center>Current Report<BR>Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934</P>
<P align=center>Date of Report (Date of earliest event reported): <B><U>June 15,
2015 </U></B></P>
<P align=center><B><U><FONT size=5>ANAVEX LIFE SCIENCES CORP.</FONT></U></B><B>
<BR></B>(Exact name of registrant as specified in its charter)</P>
<TABLE
style="BORDER-COLOR: black; FONT-SIZE: 10pt; BORDER-COLLAPSE: collapse; "
cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=top>
    <TD align=center ><B><U>Nevada </U></B></TD>
    <TD align=center width="34%"><B><U>000-51652 </U></B></TD>
    <TD align=center width="34%"><B><U>20-8365999 </U></B></TD></TR>
  <TR vAlign=top>
    <TD align=center >(State or other jurisdiction </TD>
    <TD align=center width="34%">(Commission </TD>
    <TD align=center width="34%">(IRS Employer </TD></TR>
  <TR vAlign=top>
    <TD align=center >of incorporation) </TD>
    <TD align=center width="34%">File Number) </TD>
    <TD align=center width="34%">Identification No.) </TD></TR></TABLE>
<P align=center><B><U>51 West 52nd Street, 7th Floor, New York, NY USA 10019
</U></B><BR>(Address of principal executive offices) (Zip Code)</P>
<P align=center>Registrant's telephone number, including area code
<B><U>1-844-689-3939 </U></B></P>
<P align=center><B><U>Not Applicable </U></B><BR>(Former name or former address,
if changed since last report.) </P>
<P align=justify>Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below): </P>
<P align=justify>[&nbsp; ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</P>
<P align=justify>[&nbsp; ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)</P>
<P align=justify>[&nbsp; ] Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</P>
<P align=justify>[&nbsp; ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) </P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_2></A>
<P align=justify><B>Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.</B> </P>
<P align=justify>Effective June 15, 2015 (the &#147;<U>Effective Date</U>&#148; ), the
board of directors (the &#147;<U>Board</U>&#148; ) of Anavex Life Sciences Corp., a Nevada
corporation (the &#147;<U>Company</U>&#148; ), appointed Steffen Thomas, PhD, to serve as
a member of the Board until his successor is duly elected, qualified and seated
or until his earlier resignation or removal.</P>
<P align=justify>In addition to being a member of the Board, it is anticipated
that Dr. Thomas will serve on the Audit Committee, effective as of the Effective
Date. As compensation for his services, the Company granted Dr. Thomas options
to purchase two hundred thousand (200,000) shares of common stock in the
Company, said options to vest annually over a three year period commencing on
the first anniversary of the Effective Date.</P>
<P align=justify>The Company has not entered into any transactions with Dr.
Thomas that would require disclosure pursuant to Item 404(a) of Regulation S-K
under the Exchange Act of 1934, as amended.<BR>
</P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" color=black
noShade SIZE=5>
<!--$$/page=--><A name=page_3></A>
<P align=center><B><U>SIGNATURES</U></B></P>
<P align=justify style="text-indent: 5%">Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P>
<P align=justify style="margin-left: 50%"><B>ANAVEX LIFE SCIENCES CORP.</B><BR><I><U>/s/ Christopher
Missling&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U></I><BR>Name: Christopher Missling, PhD<BR>Title: Chief Executive
Officer <BR>Date: June 17, 2015<BR></P>
<HR align=center width="100%" color=black noShade SIZE=5>

</BODY>

</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
